VALVULAR HEART DISEASE
Failure of Guideline Adherence for Intervention in Patients With Severe Mitral Regurgitation
David S. Bach, MD*,
Mazen Awais, MD,
Hitinder S. Gurm, MD and
Sarah Kohnstamm, MD
Department of Internal Medicine, Division of Cardiovascular Medicine, University of Michigan, Ann Arbor, Michigan
Manuscript received January 6, 2009;
revised manuscript received March 16, 2009,
accepted March 16, 2009.
* Reprint requests and correspondence: Dr. David S. Bach, CVC Room 2147, SPC 5853, 1500 East Medical Center Drive, Ann Arbor, Michigan 48109-5853 (Email: dbach{at}umich.edu).
Objectives: This study sought to evaluate the incidence with which adult patients with significant mitral regurgitation (MR) do not undergo surgical intervention despite guideline recommendations, and the associated considerations resulting in no intervention.
Background: Despite the existence of accepted guidelines, many patients with severe symptomatic heart valve disease might not undergo intervention.
Methods: At a single large tertiary medical center, patients were retrospectively identified who had moderate-to-severe or severe MR on echocardiographic imaging during 2005. Clinical data were reviewed to determine indications for intervention and whether surgery was performed.
Results: During 2005, 300 patients were identified with significant MR, including 188 with functional MR and 112 with organic MR. Mitral surgery was performed in 30 of 188 patients with functional MR, mostly to treat heart failure or during another cardiac surgical procedure. Mitral surgery was performed in 59 (53%) of 112 patients with organic MR. Among unoperated patients with organic MR, common reasons included stable left ventricular size or function, absence of symptoms, and prohibitive comorbidities. Using American College of Cardiology/American Heart Association guidelines, 1 or more indication for intervention was present in 39 (74%) of 53 unoperated patients. Perioperative mortality risk was not higher for patients who did not undergo surgery (median 1.2%, interquartile range [IQR] 0.4% to 3.3%) than for those who did (median 1.1%, IQR 0.6% to 5.3%; p = 0.71). During follow-up, there were 12 cardiac and 2 unexplained deaths.
Conclusions: Among patients with severe organic MR, surgical intervention occurred in approximately one-half. However, accepted guideline indications for intervention were present in the majority of unoperated patients. Objectively assessed operative risk was not prohibitive in many unoperated patients.
Key Words: mitral regurgitation mitral valve surgery operative risk guidelines adherence/compliance
|
Abbreviations and Acronyms
| | ACC = American College of Cardiology | | AHA = American Heart Association | | EF = ejection fraction | | IQR = interquartile range | | LV = left ventricle/ventricular | | MR = mitral regurgitation |
|
Related Article
-
Inside This Issue
J. Am. Coll. Cardiol. 2009 54: A28.
[Full Text]
[PDF]
This article has been cited by other articles:

|
 |

|
 |
 
B. J. L. Van den Branden, M. J. Swaans, M. C. Post, B. J. W. M. Rensing, F. D. Eefting, W. Jaarsma, and J. A. S. Van der Heyden
Percutaneous Edge-to-Edge Mitral Valve Repair in High-Surgical-Risk Patients: Do We Hit the Target?
J. Am. Coll. Cardiol. Intv.,
January 1, 2012;
5(1):
105 - 111.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Rosenhek
Almanac 2011: valvular heart disease. The national society journals present selected research that has driven recent advances in clinical cardiology
Heart,
December 15, 2011;
97(24):
2007 - 2017.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. J. van Bommel, N. A. Marsan, V. Delgado, C. J. W. Borleffs, E. P. M. van Rijnsoever, M. J. Schalij, and J. J. Bax
Cardiac Resynchronization Therapy as a Therapeutic Option in Patients With Moderate-Severe Functional Mitral Regurgitation and High Operative Risk
Circulation,
August 23, 2011;
124(8):
912 - 919.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. H. Adams, J. Chikwe, F. Filsoufi, and A. C. Anyanwu
The Year in Cardiovascular Surgery
J. Am. Coll. Cardiol.,
March 29, 2011;
57(13):
1425 - 1444.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. L. d'Arcy, B. D. Prendergast, J. B. Chambers, S. G. Ray, and B. Bridgewater
Valvular heart disease: the next cardiac epidemic
Heart,
January 15, 2011;
97(2):
91 - 93.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. F. Bolling, S. Li, S. M. O'Brien, J. M. Brennan, R. L. Prager, and J. S. Gammie
Predictors of Mitral Valve Repair: Clinical and Surgeon Factors
Ann. Thorac. Surg.,
December 1, 2010;
90(6):
1904 - 1912.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. L. McPhail, J. Weiland, J. D. Acton, M. Ednick, A. Chima, R. VanDyke, M. C. Fenchel, R. S. Amin, and M. Seid
Improving Evidence-Based Care in Cystic Fibrosis Through Quality Improvement
Arch Pediatr Adolesc Med,
October 1, 2010;
164(10):
957 - 960.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. H. Adams, R. Rosenhek, and V. Falk
Degenerative mitral valve regurgitation: best practice revolution
Eur. Heart J.,
August 2, 2010;
31(16):
1958 - 1966.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Enriquez-Sarano and T. M. Sundt III
Early Surgery Is Recommended for Mitral Regurgitation
Circulation,
February 16, 2010;
121(6):
804 - 812.
[Full Text]
[PDF]
|
 |
|
|